Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-03
1994-06-07
Rotman, Alan L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546236, 546237, C07D21122, C07D21120
Patent
active
053190874
ABSTRACT:
This invention provides trans-3,4 1-substituted-3-substituted-4-methyl-4-(3-substituted phenyl)piperidines as opioid antagonists capable of blocking the mu or kappa receptors in the brain.
REFERENCES:
patent: 3991199 (1976-11-01), Berger
patent: 4081450 (1978-03-01), Zimmerman
patent: 4141980 (1979-02-01), Berger
patent: 4191771 (1980-03-01), Zimmerman
patent: 4581456 (1986-04-01), Barnett
Leander et al., European Journal of Pharmacology, 81, 185-192.
Leander et al., Drug Development Research, 4:421-427 (1984).
Leander, The Journal of Pharmacology and Experimental Therapeutics, vol. 224, No. 1, 89-94 (1983).
Zimmerman et al., Nature, vol. 275, Sep. 28, 1978, pp. 332-334.
Mitch Charles H.
Zimmerman Dennis M.
Eli Lilly and Company
Rotman Alan L.
Vorndran-Jones MaCharri R.
Whitaker Leroy
LandOfFree
Piperidine opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine opioid antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793741